DE60036929D1 - Gentherapeutika - Google Patents

Gentherapeutika

Info

Publication number
DE60036929D1
DE60036929D1 DE60036929T DE60036929T DE60036929D1 DE 60036929 D1 DE60036929 D1 DE 60036929D1 DE 60036929 T DE60036929 T DE 60036929T DE 60036929 T DE60036929 T DE 60036929T DE 60036929 D1 DE60036929 D1 DE 60036929D1
Authority
DE
Germany
Prior art keywords
gene
affinity
gene therapy
functional substance
efficacious amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60036929T
Other languages
English (en)
Other versions
DE60036929T2 (de
Inventor
Ikunoshin Kato
Kiyozo Asada
Mitsuhiro Ueno
Kimikazu Hashino
Hirofumi Yoshioka
Keiji Tanaka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takara Bio Inc
Original Assignee
Takara Bio Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takara Bio Inc filed Critical Takara Bio Inc
Publication of DE60036929D1 publication Critical patent/DE60036929D1/de
Application granted granted Critical
Publication of DE60036929T2 publication Critical patent/DE60036929T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2810/00—Vectors comprising a targeting moiety
    • C12N2810/40—Vectors comprising a peptide as targeting moiety, e.g. a synthetic peptide, from undefined source

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60036929T 1999-03-23 2000-03-14 Gentherapeutika Expired - Lifetime DE60036929T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP7859199 1999-03-23
JP7859199 1999-03-23
PCT/JP2000/001533 WO2000056368A1 (fr) 1999-03-23 2000-03-14 Therapeutique genique

Publications (2)

Publication Number Publication Date
DE60036929D1 true DE60036929D1 (de) 2007-12-13
DE60036929T2 DE60036929T2 (de) 2008-08-07

Family

ID=13666162

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60036929T Expired - Lifetime DE60036929T2 (de) 1999-03-23 2000-03-14 Gentherapeutika

Country Status (9)

Country Link
US (1) US20060166924A1 (de)
EP (1) EP1163912B1 (de)
KR (1) KR100674140B1 (de)
CN (1) CN1225285C (de)
AT (1) ATE376840T1 (de)
AU (1) AU2944100A (de)
DE (1) DE60036929T2 (de)
TW (1) TWI272107B (de)
WO (1) WO2000056368A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100888915B1 (ko) 2001-08-15 2009-03-16 다카라 바이오 가부시키가이샤 항원특이적 세포상해성 ｔ 세포 확대배양방법
ES2397319T3 (es) 2002-03-25 2013-03-06 Takara Bio Inc. Proceso para producir linfocitos citotóxicos
US8927273B2 (en) 2003-08-22 2015-01-06 Takara Bio Inc. Process for producing cytotoxic lymphocytes
EP1916302A4 (de) 2005-08-17 2009-10-21 Takara Bio Inc Verfahren zur herstellung von lymphozyten
JP5156382B2 (ja) * 2005-09-30 2013-03-06 タカラバイオ株式会社 Ｔ細胞集団の製造方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5686278A (en) * 1994-03-25 1997-11-11 Indiana University Foundation Methods for enhanced retrovirus-mediated gene transfer
CA2158926A1 (en) * 1994-05-13 1995-11-14 Douglas J. Jolly Compositions and methods for targeting gene delivery vehicles
GB9506466D0 (en) * 1994-08-26 1995-05-17 Prolifix Ltd Cell cycle regulated repressor and dna element
FR2726005B1 (fr) * 1994-10-10 1997-01-03 Adim Lignees immortalisees de cellules endotheliales cerebrales et leurs applications au traitement de differents troubles ou maladies primaires et secondaires neurologiques ou psychiatriques
JP3343357B2 (ja) * 1995-11-13 2002-11-11 寳酒造株式会社 レトロウイルスによる標的細胞への遺伝子導入方法
WO1997031656A1 (fr) * 1996-03-01 1997-09-04 Dnavec Research Inc. Composition pour introduire de maniere stable des genes dans des cellules hepatiques et procede pour introduire des genes a l'aide de cette composition
ATE350482T1 (de) * 1998-07-01 2007-01-15 Takara Bio Inc Gentransfermethoden

Also Published As

Publication number Publication date
EP1163912A1 (de) 2001-12-19
WO2000056368A1 (fr) 2000-09-28
CN1345248A (zh) 2002-04-17
TWI272107B (en) 2007-02-01
AU2944100A (en) 2000-10-09
CN1225285C (zh) 2005-11-02
US20060166924A1 (en) 2006-07-27
ATE376840T1 (de) 2007-11-15
KR100674140B1 (ko) 2007-01-26
EP1163912A4 (de) 2003-08-06
EP1163912B1 (de) 2007-10-31
DE60036929T2 (de) 2008-08-07
KR20010102547A (ko) 2001-11-15

Similar Documents

Publication Publication Date Title
DK0774005T3 (da) Overfladeudtrykkelse af enzymer i genorienteret prodrug-terapi
ATE375142T1 (de) Medizinische aerosolformulierungen
HN1998000143A (es) Tetrahidronaftalenos substituidos y compuestos analogos.
TR199800046A2 (xx) Aktif maddeler yarat�lmas� i�in n�kleik asit olu�umu.
NL980011I2 (nl) 7-Piperazinyl- of 7-Morfolino-4-oxo-chinoline-3-carbonzuurderivaten, hun bereiding en hun gebruik als antimicrobiële middelen.
SV2002000245A (es) Oxazolidinonas substituidas y su uso ref. lea 34122-sv
ATE231509T1 (de) 1,5-dihydro-pyrazolo 3,4-d)-pyrimidinon-derivate
NO330934B1 (no) Flytende farmasoytisk preparat samt anvendelse og fremstilling derav.
PT751939E (pt) Naftilamidas como agentes para o sistema nervoso central
TR200200883T2 (tr) 2-ikameli 1,1-bifenil-2-karbonamidler, imalat yöntemleri, ilaç olarak kullanılmaları
BR0009170A (pt) ácidos nucléicos akt, polipeptìdeos e uso dos mesmos
DE60036929D1 (de) Gentherapeutika
DE60132443D1 (de) In lebenden zielzellen
DE60142899D1 (de) Verbindungen für den transfer von oligonukleotiden
DE69414194T2 (de) Aminosäurederivate und ihre Verwendung als Enkephalinase-Inhibitoren
FI801228A (fi) 6-substituerade 11-alkylen-morfantridiner foerfaranden foer deras framstaellning och terapeutiska medel innehaollande dessa
DE69612056D1 (de) Terpenderivate (sarcodictyine) als antikrebsmittel
SE9803272D0 (sv) A drug for cell regeneration
DK52685D0 (da) N,3-diacyl-2-oxindol-1-carboxamid-forbindelser og mellemprodukter ved deres fremstilling samt farmaceutisk praeparat
TR200201148T2 (tr) Haşerat ilacı terkipleri ve metodları.
ATE305612T1 (de) Reporterverbindungen und verfahren zur auffindung von hochspezifische proteaseaktivität
NL350033I1 (nl) Gefuseerde middelen voor biologische controle.
WO2000063348A3 (fr) Composition pharmaceutique comprenant des cellules nkt activees par des pim, et son utilisation en therapie
DK592885D0 (da) 2-azolylmethyl-3-difluorbenzyloxy-2,3-dihydrofluor-benzo(b)thiophener, fremgangsmaade til deres fremstilling og kompositioner indeholdendeforbindelserne
ME00088B (me) Farmaceutski preparat i njegova priprema

Legal Events

Date Code Title Description
8364 No opposition during term of opposition